APA

Jayaram H. N., Ahluwalia G. S., Dion R. L., Gebeyehu G., Marquez V. E., Kelley J. A., Robins R. K., Cooney D. A. & Johns D. G. (19831028). Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. : Biochemical pharmacology.

Chicago

Jayaram H N, Ahluwalia G S, Dion R L, Gebeyehu G, Marquez V E, Kelley J A, Robins R K, Cooney D A and Johns D G. 19831028. Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. : Biochemical pharmacology.

Harvard

Jayaram H. N., Ahluwalia G. S., Dion R. L., Gebeyehu G., Marquez V. E., Kelley J. A., Robins R. K., Cooney D. A. and Johns D. G. (19831028). Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. : Biochemical pharmacology.

MLA

Jayaram H N, Ahluwalia G S, Dion R L, Gebeyehu G, Marquez V E, Kelley J A, Robins R K, Cooney D A and Johns D G. Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. : Biochemical pharmacology. 19831028.